These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 35155257)

  • 21. NEDD8-mediated neddylation is required for human endometrial stromal proliferation and decidualization.
    Liao Y; Jiang Y; He H; Ni H; Tu Z; Zhang S; Wang B; Lou J; Quan S; Wang H
    Hum Reprod; 2015 Jul; 30(7):1665-76. PubMed ID: 26003431
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of NEDD8 Pathway Inhibition in Preclinical Models of Poorly Differentiated, Clinically Aggressive Colorectal Cancer.
    Picco G; Petti C; Sassi F; Grillone K; Migliardi G; Rossi T; Isella C; Di Nicolantonio F; Sarotto I; Sapino A; Bardelli A; Trusolino L; Bertotti A; Medico E
    J Natl Cancer Inst; 2017 Feb; 109(2):. PubMed ID: 27771609
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neddylation: a novel modulator of the tumor microenvironment.
    Zhou L; Jiang Y; Luo Q; Li L; Jia L
    Mol Cancer; 2019 Apr; 18(1):77. PubMed ID: 30943988
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeting the neddylation pathway to suppress the growth of prostate cancer cells: therapeutic implication for the men's cancer.
    Wang X; Li L; Liang Y; Li C; Zhao H; Ye D; Sun M; Jeong LS; Feng Y; Fu S; Jia L; Guo X
    Biomed Res Int; 2014; 2014():974309. PubMed ID: 25093192
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proteomics identifies neddylation as a potential therapy target in small intestinal neuroendocrine tumors.
    Fotouhi O; Kjellin H; Juhlin CC; Pan Y; Vesterlund M; Ghaderi M; Yousef A; Andersson-Sand H; Kharaziha P; Caramuta S; Kjellman M; Zedenius J; Larsson C; Orre LM
    Oncogene; 2019 Oct; 38(43):6881-6897. PubMed ID: 31406256
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neddylation inhibitor MLN4924 suppresses growth and migration of human gastric cancer cells.
    Lan H; Tang Z; Jin H; Sun Y
    Sci Rep; 2016 Apr; 6():24218. PubMed ID: 27063292
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Anti-Tumor Activity of the NEDD8 Inhibitor Pevonedistat in Neuroblastoma.
    Foster JH; Barbieri E; Zhang L; Scorsone KA; Moreno-Smith M; Zage P; Horton TM
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34207315
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Overactivated neddylation pathway as a therapeutic target in lung cancer.
    Li L; Wang M; Yu G; Chen P; Li H; Wei D; Zhu J; Xie L; Jia H; Shi J; Li C; Yao W; Wang Y; Gao Q; Jeong LS; Lee HW; Yu J; Hu F; Mei J; Wang P; Chu Y; Qi H; Yang M; Dong Z; Sun Y; Hoffman RM; Jia L
    J Natl Cancer Inst; 2014 Jun; 106(6):dju083. PubMed ID: 24853380
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neddylation inhibitor, MLN4924 suppresses angiogenesis in huvecs and solid cancers:
    Shi CS; Kuo KL; Lin WC; Chen MS; Liu SH; Liao SM; Hsu CH; Chang YW; Chang HC; Huang KH
    Am J Cancer Res; 2020; 10(3):953-964. PubMed ID: 32266102
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Suppression of tumor angiogenesis by targeting the protein neddylation pathway.
    Yao WT; Wu JF; Yu GY; Wang R; Wang K; Li LH; Chen P; Jiang YN; Cheng H; Lee HW; Yu J; Qi H; Yu XJ; Wang P; Chu YW; Yang M; Hua ZC; Ying HQ; Hoffman RM; Jeong LS; Jia LJ
    Cell Death Dis; 2014 Feb; 5(2):e1059. PubMed ID: 24525735
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The neddylation-cullin 2-RBX1 E3 ligase axis targets tumor suppressor RhoB for degradation in liver cancer.
    Xu J; Li L; Yu G; Ying W; Gao Q; Zhang W; Li X; Ding C; Jiang Y; Wei D; Duan S; Lei Q; Li P; Shi T; Qian X; Qin J; Jia L
    Mol Cell Proteomics; 2015 Mar; 14(3):499-509. PubMed ID: 25540389
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of the NEDD8 conjugation pathway induces calcium-dependent compensatory activation of the pro-survival MEK/ERK pathway in acute lymphoblastic leukemia.
    Zheng S; Leclerc GM; Li B; Swords RT; Barredo JC
    Oncotarget; 2018 Jan; 9(5):5529-5544. PubMed ID: 29464016
    [No Abstract]   [Full Text] [Related]  

  • 33. Neddylation, a novel paradigm in liver cancer.
    Delgado TC; Barbier-Torres L; Zubiete-Franco I; Lopitz-Otsoa F; Varela-Rey M; Fernández-Ramos D; Martínez-Chantar ML
    Transl Gastroenterol Hepatol; 2018; 3():37. PubMed ID: 30050997
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeting NEDDylation is a Novel Strategy to Attenuate Cisplatin-induced Nephrotoxicity.
    Jones TM; Espitia CM; Chipollini J; Lee BR; Wertheim JA; Carew JS; Nawrocki ST
    Cancer Res Commun; 2023 Feb; 3(2):245-257. PubMed ID: 36860653
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MLN4924 suppresses neddylation and induces cell cycle arrest, senescence, and apoptosis in human osteosarcoma.
    Zhang Y; Shi CC; Zhang HP; Li GQ; Li SS
    Oncotarget; 2016 Jul; 7(29):45263-45274. PubMed ID: 27223074
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of neddylation-related proteins in melanoma cell lines and the effect of neddylation on melanoma proliferation.
    Cheng F; He R; Zhang L; Li H; Zhang W; Ji X; Kong F; Sun J; Chen S
    Oncol Lett; 2014 May; 7(5):1645-1650. PubMed ID: 24765193
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunomodulatory effect of NEDD8-activating enzyme inhibition in Multiple Myeloma: upregulation of NKG2D ligands and sensitization to Natural Killer cell recognition.
    Petillo S; Capuano C; Molfetta R; Fionda C; Mekhloufi A; Pighi C; Antonangeli F; Zingoni A; Soriani A; Petrucci MT; Galandrini R; Paolini R; Santoni A; Cippitelli M
    Cell Death Dis; 2021 Sep; 12(9):836. PubMed ID: 34482362
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ARHGAP25 Inhibits Pancreatic Adenocarcinoma Growth by Suppressing Glycolysis via AKT/mTOR Pathway.
    Huang WK; Chen Y; Su H; Chen TY; Gao J; Liu Y; Yeh CN; Li S
    Int J Biol Sci; 2021; 17(7):1808-1820. PubMed ID: 33994864
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effective targeting of the ubiquitin-like modifier NEDD8 for lung adenocarcinoma treatment.
    Jiang Y; Cheng W; Li L; Zhou L; Liang Y; Zhang W; Chen W; Wang S; Zhao H; Chen G; Zhou W; Ji G; Zhang Y; Hoffman RM; Wang M; Jia L
    Cell Biol Toxicol; 2020 Aug; 36(4):349-364. PubMed ID: 31907687
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Schlafen 11 (SLFN11) Kills Cancer Cells Undergoing Unscheduled Re-replication.
    Murai J; Ceribelli M; Fu H; Redon CE; Jo U; Murai Y; Aladjem MI; Thomas CJ; Pommier Y
    Mol Cancer Ther; 2023 Aug; 22(8):985-995. PubMed ID: 37216280
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.